Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

BackgroundWe assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF) using the Korean Health Insurance claims database.MethodsWe collected data on newly prescribed sitagliptin, vildagliptin, and pioglitazone between January 1, 2009 and Decemb...

Full description

Bibliographic Details
Main Authors: Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2015-06-01
Series:Diabetes & Metabolism Journal
Subjects:
Dipeptidyl-peptidase IV inhibitors
Heart failure
Pioglitazone
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-247.pdf

Internet

http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-247.pdf

Similar Items